enVVeno Medical Corporati... (NVNO)
NASDAQ: NVNO
· Real-Time Price · USD
5.00
0.09 (1.83%)
At close: Aug 18, 2025, 3:59 PM
5.00
0.00%
After-hours: Aug 18, 2025, 04:10 PM EDT
1.83% (1D)
| Bid | 4.83 |
| Market Cap | 96.14M |
| Revenue (ttm) | 812K |
| Net Income (ttm) | -23.07M |
| EPS (ttm) | -1.2 |
| PE Ratio (ttm) | -4.16 |
| Forward PE | -4.6 |
| Analyst | n/a |
| Ask | 5.62 |
| Volume | 157,924 |
| Avg. Volume (20D) | 130,040 |
| Open | 4.92 |
| Previous Close | 4.91 |
| Day's Range | 4.82 - 5.09 |
| 52-Week Range | 2.03 - 5.70 |
| Beta | 1.01 |
About NVNO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NVNO
Website n/a
2 months ago
+10.06%
enVVeno Medical shares are trading higher after th...
Unlock content with
Pro Subscription
10 months ago
-28%
EnVVeno Medical shares are trading lower after the company announced the pricing of a $15 million public offering of 4.3 million shares at $3.50 per share.
2 weeks ago · accessnewswire.com
enVVeno Medical Reports Second Quarter 2025 Financial Results and Provides Corporate Update- Cash burn of $3.8 million in Q2 remains in line with projected quarterly range - Cash and investments are sufficient to fund operations through Q3'2026 at current cash burn rate - Commercial readine...
3 months ago · accessnewswire.com
enVVeno Medical Appoints Jennifer Bright as Chief Financial OfficerIRVINE, CA / ACCESS Newswire / May 19, 2025 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of deep venous disease, ...